RECRUITING

TENS Used for Pain Management During Office Cystoscopy Botox Injections

Description

The purpose of this study is to determine how Transcutaneous Electric Nerve Stimulation (TENS) units affects pain management during office cystoscopic Botox injections and patient satisfaction with the procedure .

Conditions

Overactive Bladder
Talk to us

Related Conditions:

Overactive Bladder

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to determine how Transcutaneous Electric Nerve Stimulation (TENS) units affects pain management during office cystoscopic Botox injections and patient satisfaction with the procedure .

Transcutaneous Electric Nerve Stimulation For Pain Control During Office Intra-detrusor Onabotulinumtoxin A Cystoscopy Injection for Overactive Bladder: A Phase III Randomized Controlled Trial

TENS Used for Pain Management During Office Cystoscopy Botox Injections

Condition
Overactive Bladder
Intervention / Treatment

-

Contacts and Locations

Rochester

Mayo Clinic in Rochester, Rochester, Minnesota, United States, 55905

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Females age 18 years or older
  • * Scheduled to receive intra-detrusor Onabotulinumtoxin-A injection for Overactive Bladder in the outpatient clinic
  • * Reads, speaks, and understands the English language
  • * Able to understand the requirements of the study, including randomization
  • * Willing and able to provide written informed consent
  • * Previous use of TENS therapy within one year prior to study enrollment
  • * Has a spouse or first degree relative who has previously used TENS therapy within one year prior to study enrollment
  • * Currently has an implanted pacemaker or automatic cardiac defibrillator
  • * History of epilepsy
  • * Currently pregnant or within 12 weeks postpartum
  • * Unwilling to be randomized

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Mayo Clinic,

John A Occhino, MD, MS, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

2025-12